-DOCSTART- -X- O
The -X- _ O
tumor -X- _ B-Patient
necrosis -X- _ I-Patient
factor -X- _ I-Patient
receptor -X- _ I-Patient
( -X- _ I-Patient
TNF-R -X- _ I-Patient
) -X- _ I-Patient
-associated -X- _ I-Patient
factor -X- _ I-Patient
( -X- _ I-Patient
TRAF -X- _ I-Patient
) -X- _ I-Patient
family -X- _ I-Patient
of -X- _ O
intracellular -X- _ O
proteins -X- _ O
were -X- _ O
originally -X- _ O
identified -X- _ O
as -X- _ O
signaling -X- _ O
adaptors -X- _ O
that -X- _ O
bind -X- _ O
directly -X- _ O
to -X- _ O
the -X- _ O
cytoplasmic -X- _ O
regions -X- _ O
of -X- _ O
receptors -X- _ O
of -X- _ O
the -X- _ O
TNF-R -X- _ O
superfamily. -X- _ O
The -X- _ O
past -X- _ O
decade -X- _ O
has -X- _ O
witnessed -X- _ O
rapid -X- _ O
expansion -X- _ O
of -X- _ O
receptor -X- _ O
families -X- _ O
identified -X- _ O
to -X- _ O
employ -X- _ O
TRAFs -X- _ O
for -X- _ O
signaling. -X- _ O
These -X- _ O
include -X- _ O
Toll-like -X- _ B-Intervention
receptors -X- _ I-Intervention
( -X- _ I-Intervention
TLRs -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ I-Intervention
NOD-like -X- _ I-Intervention
receptors -X- _ I-Intervention
( -X- _ I-Intervention
NLRs -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ I-Intervention
RIG-I-like -X- _ I-Intervention
receptors -X- _ I-Intervention
( -X- _ I-Intervention
RLRs -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ I-Intervention
T -X- _ I-Intervention
cell -X- _ I-Intervention
receptor -X- _ I-Intervention
, -X- _ I-Intervention
IL-1 -X- _ I-Intervention
receptor -X- _ I-Intervention
family -X- _ I-Intervention
, -X- _ I-Intervention
IL-17 -X- _ I-Intervention
receptors -X- _ I-Intervention
, -X- _ I-Intervention
IFN -X- _ I-Intervention
receptors -X- _ I-Intervention
and -X- _ I-Intervention
TGFβ -X- _ I-Intervention
receptors. -X- _ I-Intervention
In -X- _ O
addition -X- _ O
to -X- _ O
their -X- _ O
role -X- _ O
as -X- _ O
adaptor -X- _ O
proteins -X- _ O
, -X- _ O
most -X- _ O
TRAFs -X- _ O
also -X- _ O
act -X- _ O
as -X- _ O
E3 -X- _ O
ubiquitin -X- _ O
ligases -X- _ O
to -X- _ O
activate -X- _ O
downstream -X- _ O
signaling -X- _ O
events. -X- _ O
TRAF-dependent -X- _ B-Comparison
signaling -X- _ I-Comparison
pathways -X- _ I-Comparison
typically -X- _ I-Comparison
lead -X- _ I-Comparison
to -X- _ I-Comparison
the -X- _ I-Comparison
activation -X- _ I-Comparison
of -X- _ I-Comparison
nuclear -X- _ I-Comparison
factor-κBs -X- _ I-Comparison
( -X- _ I-Comparison
NF-κBs -X- _ I-Comparison
) -X- _ I-Comparison
, -X- _ I-Comparison
mitogen-activated -X- _ I-Comparison
protein -X- _ I-Comparison
kinases -X- _ I-Comparison
( -X- _ I-Comparison
MAPKs -X- _ I-Comparison
) -X- _ I-Comparison
, -X- _ I-Comparison
or -X- _ I-Comparison
interferon-regulatory -X- _ I-Comparison
factors -X- _ I-Comparison
( -X- _ I-Comparison
IRFs -X- _ I-Comparison
) -X- _ I-Comparison
. -X- _ O
Compelling -X- _ O
evidence -X- _ O
obtained -X- _ O
from -X- _ O
germ-line -X- _ B-Outcome
and -X- _ I-Outcome
cell-specific -X- _ I-Outcome
TRAF-deficient -X- _ I-Outcome
mice -X- _ I-Outcome
demonstrates -X- _ I-Outcome
that -X- _ I-Outcome
each -X- _ I-Outcome
TRAF -X- _ I-Outcome
plays -X- _ I-Outcome
indispensable -X- _ I-Outcome
and -X- _ I-Outcome
non-redundant -X- _ I-Outcome
physiological -X- _ I-Outcome
roles -X- _ I-Outcome
, -X- _ I-Outcome
regulating -X- _ I-Outcome
innate -X- _ I-Outcome
and -X- _ I-Outcome
adaptive -X- _ I-Outcome
immunity -X- _ I-Outcome
, -X- _ I-Outcome
embryonic -X- _ I-Outcome
development -X- _ I-Outcome
, -X- _ I-Outcome
tissue -X- _ I-Outcome
homeostasis -X- _ I-Outcome
, -X- _ I-Outcome
stress -X- _ I-Outcome
response -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
bone -X- _ I-Outcome
metabolism. -X- _ I-Outcome
Notably -X- _ O
, -X- _ O
mounting -X- _ O
evidence -X- _ O
implicates -X- _ O
TRAFs -X- _ O
in -X- _ O
the -X- _ O
pathogenesis -X- _ O
of -X- _ O
human -X- _ O
diseases -X- _ O
such -X- _ O
as -X- _ O
cancers -X- _ O
and -X- _ O
autoimmune -X- _ O
diseases -X- _ O
, -X- _ O
which -X- _ O
has -X- _ O
sparked -X- _ O
new -X- _ O
appreciation -X- _ O
and -X- _ O
interest -X- _ O
in -X- _ O
TRAF -X- _ O
research. -X- _ O
This -X- _ O
review -X- _ O
presents -X- _ O
an -X- _ O
overview -X- _ O
of -X- _ O
the -X- _ O
current -X- _ O
knowledge -X- _ O
of -X- _ O
TRAFs -X- _ O
, -X- _ O
with -X- _ O
an -X- _ O
emphasis -X- _ O
on -X- _ O
recent -X- _ O
findings -X- _ O
concerning -X- _ O
TRAF -X- _ O
molecules -X- _ O
in -X- _ O
signaling -X- _ O
and -X- _ O
in -X- _ O
human -X- _ O
diseases -X- _ O
. -X- _ O

